BERRT: Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder

Sponsor
University of Tulsa (Other)
Overall Status
Recruiting
CT.gov ID
NCT02242110
Collaborator
(none)
20
1
1
155
0.1

Study Details

Study Description

Brief Summary

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. This study will assess the efficacy in individuals diagnosed with bipolar disorder.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ERRT-Bipolar Disorder
N/A

Detailed Description

This pilot study will examine the efficacy of Exposure, Relaxation, & Rescripting Therapy (ERRT) on chronic nightmares in trauma-exposed adults diagnosed with bipolar disorder (B-ERRT), as these individuals have been excluded from past clinical trials. Eligible participants will be assessed prior to starting treatment. B-ERRT will be conducted once a week for approximately five consecutive weeks for approximately two hours per session. Each treatment session focuses on one of the following topics/skills: psychoeducation regarding trauma, nightmares, and sleep disturbances on bipolar disorder, relaxation techniques, exposure to the trauma-nightmare, and relapse prevention. Participants will then be asked to complete two to three follow-up assessments, 1-week, 3-months, and potentially 1-year after the end of the treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of a Brief Treatment for Chronic Nightmares Among Trauma-Exposed Persons With Bipolar Disorder
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
May 1, 2027
Anticipated Study Completion Date :
May 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nightmare Treatment

The nightmare treatment, Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder (ERRT-Bipolar Disorder), is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

Behavioral: ERRT-Bipolar Disorder
The nightmare treatment, called Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder, is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.
Other Names:
  • ERRT
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Past Week Nightmare Frequency [Pre, One week, Three Months]

      This fill-in-the-blank variable assesses the number of nightmares experienced in the past week (range = 0 - X nightmares) at each assessment (baseline, one week following treatment, and three months following treatment). Higher values indicate more nightmares (worse outcome).

    Secondary Outcome Measures

    1. Change in Clinician Administered PTSD Scale Symptoms [Pre, One week, Three Months]

      This semi-structured clinical interview assesses severity of each of 30 items

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Nightmares at least once per week for the past month

    • Formal diagnosis of Bipolar disorder (I or II)

    • Exposure to traumatic event (1+ months ago)

    • Stable on bipolar medication for at least 2 months

    Exclusion Criteria:
    • A traumatic event within the last month

    • Intellectual disability

    • Current or recent mania/hypomania within the last 3 months

    • Suicide attempt or hospitalization within the last 3 months

    • Current or untreated substance use disorder within the past 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Tulsa Tulsa Oklahoma United States 74104

    Sponsors and Collaborators

    • University of Tulsa

    Investigators

    • Principal Investigator: Joanne L Davis, PhD, University of Tulsa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Joanne Davis, PI, University of Tulsa
    ClinicalTrials.gov Identifier:
    NCT02242110
    Other Study ID Numbers:
    • TU1457R1
    First Posted:
    Sep 16, 2014
    Last Update Posted:
    May 27, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Joanne Davis, PI, University of Tulsa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 27, 2022